XML 37 R22.htm IDEA: XBRL DOCUMENT
v3.5.0.2

QUARTERLY FINANCIAL DATA (UNAUDITED) | 12 Months Ended
--- | ---
Jun. 30, 2016
Quarterly Financial Information Disclosure [Abstract] |
QUARTERLY FINANCIAL DATA (UNAUDITED) | Refer to Management's Discussion and Analysis of Financial Condition and Results of Operations in Part II, Item 7 in this Form 10-K for explanations of items which impacted fiscal years 2016 and 2015 revenues, operating and net (loss) income. Summarized quarterly data for fiscal years 2016 and 2015 follows:
|  | Quarter Ended |  |
|  | September 30 |  | December 31 |  | March 31(a) |  | June 30(a) |  | Year Ended
|  | (Dollars in thousands, except per share amounts)
2016 |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 450,130 |  |  | $ | 450,467 |  |  | $ | 442,565 |  |  | $ | 447,707 |  |  | $ | 1,790,869 |
Cost of service and product revenues, excluding depreciation and amortization |  | 260,804 |  |  | 267,056 |  |  | 260,046 |  |  | 259,623 |  |  | 1,047,529 |
Operating income (loss) |  | 4,276 |  |  | (2,883 | ) |  | 5,621 |  |  | 10,600 |  |  | 17,614 |
Net (loss) income(b) |  | (808 | ) |  | (13,986 | ) |  | (2,084 | ) |  | 5,562 |  |  | (11,316 | )
Net (loss) income per basic and diluted share(d) |  | (0.02 | ) |  | (0.29 | ) |  | (0.04 | ) |  | 0.12 |  |  | (0.23 | )
|  | Quarter Ended |  |
|  | September 30 |  | December 31 |  | March 31 |  | June 30 |  | Year Ended
|  | (Dollars in thousands, except per share amounts)
2015 |  |  |  |  |  |  |  |  |  |
Revenues |  | $ | 464,551 |  |  | $ | 455,887 |  |  | $ | 453,960 |  |  | $ | 462,889 |  |  | $ | 1,837,287 |
Cost of service and product revenues, excluding depreciation and amortization |  | 268,664 |  |  | 268,049 |  |  | 261,947 |  |  | 264,615 |  |  | 1,063,275 |
Operating (loss) income |  | (754 | ) |  | (671 | ) |  | 5,402 |  |  | (446 | ) |  | 3,531 |
Loss from continuing operations(b) |  | (9,843 | ) |  | (16,663 | ) |  | (4,763 | ) |  | (1,943 | ) |  | (33,212 | )
Loss from discontinued operations(c) |  | — |  |  | — |  |  | — |  |  | (630 | ) |  | (630 | )
Net loss(b)(c) |  | (9,843 | ) |  | (16,663 | ) |  | (4,763 | ) |  | (2,573 | ) |  | (33,842 | )
Loss from continuing operations per share, basic and diluted(d) |  | (0.18 | ) |  | (0.30 | ) |  | (0.09 | ) |  | (0.04 | ) |  | (0.60 | )
Loss from discontinued operations per share, basic and diluted |  | — |  |  | — |  |  | — |  |  | (0.01 | ) |  | (0.01 | )
Net loss per basic and diluted share(d) |  | (0.18 | ) |  | (0.30 | ) |  | (0.09 | ) |  | (0.05 | ) |  | (0.62 | )
_______________________________________________________________________________
(a) | During the third quarter of fiscal year 2016, the Company recorded a cumulative adjustment to correct prior period errors that related to the overstatement of interest expense, insurance expense and telephone expense, and the understatement of depreciation expense in prior periods. The impact of these items on the Company's Consolidated Statement of Operations decreased interest expense by $0.6 million, decreased site operating expenses by $0.5 million, increased depreciation expense by $0.3 million, and decreased net loss by $0.8 million. During the fourth quarter of fiscal year 2016, the Company recorded an adjustment to correct an error related to the overstatement of depreciation expense in prior periods. The impact of this item on the Company's Consolidated Statement of Operations decreased depreciation expense and net loss by $1.1 million. Because these errors were not material to the Company's consolidated financial statements for any prior periods, the respective quarter, or fiscal year, the Company recorded adjustments to correct the errors during each respective quarter for fiscal 2016.
(b) | During the second quarter of fiscal year 2016, the Company recorded a $13.0 million other than temporary impairment charge on its investment in EEG. During the second quarter of fiscal year 2015, the Company recorded a $4.7 million other than temporary impairment charge and $6.9 million of its share of a deferred tax valuation allowance on its investment in EEG.
(c) | During the fourth quarter of fiscal year 2015, the Company recorded expenses of $0.6 million in discontinued operations related to legal fees related to Trade Secret.
(d) | Total is an annual recalculation; line items calculated quarterly may not sum to total.

X
- References No definition available. + Details
Name: | us-gaap_QuarterlyFinancialInformationDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for quarterly financial data. Includes, but is not limited to, tabular presentation of financial information for fiscal quarters, effect of year-end adjustments, and an explanation of matters or transactions that affect comparability of the information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=68076893&loc=d3e1570-108306 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e765-108305 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=68064558&loc=d3e725-108305 + Details
Name: | us-gaap_QuarterlyFinancialInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration